Search results for "muscle relaxant"

showing 3 items of 13 documents

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

2019

Background: Results from retrospective studies suggest that use of neuromuscular blocking agents during general anaesthesia might be linked to postoperative pulmonary complications. We therefore aimed to assess whether the use of neuromuscular blocking agents is associated with postoperative pulmonary complications. Methods: We did a multicentre, prospective observational cohort study. Patients were recruited from 211 hospitals in 28 European countries. We included patients (aged ≥18 years) who received general anaesthesia for any in-hospital procedure except cardiac surgery. Patient characteristics, surgical and anaesthetic details, and chart review at discharge were prospectively collecte…

Pulmonary and Respiratory Medicinepulmonary complications muscle relaxants Post-anaesthesia complicationsNeuromuscular Blockadepulmonary complication muscle relaxantneuromuscular block ; postoperative pulmonary complicationbusiness.industryRetrospective cohort studypost-operative pulmonary complicationsNeuromuscular monitoringNeuromuscular Blocking AgentsSugammadexNOAnaesthesia03 medical and health sciences0302 clinical medicine030228 respiratory systemAnesthesiaMedicineGeneral anaesthesiaNeuromuscular Agents030212 general & internal medicineMED/41 - ANESTESIOLOGIAProspective cohort studybusinessmedicine.drug
researchProduct

Diagnostic therapeutic flow-charts for low-back pain patient : the Italian clinical guidelines

2006

antidepressant agentmuscle relaxant agentnonsteroid antiinflammatory agentparacetamol addictiondiagnostic proceduredrowsinessexercisehumanhyperthermic therapyItalylow back painmassagepractice guidelinereview Disability EvaluationHumansItalyLow Back Pain
researchProduct

Muskelrelaxantien, 4. Mitt. Monoacylbutyroguanamine

1986

Die Umsetzung von Butyroguanamin (1) mit den Carbonsaureanhydriden 2a−f bei 80–120° fuhrt zu den Monoacylbutyroguanaminen 3a−f, deren Struktur durch IR-, 1H-NMR- und MS-Spektren untermauert wird. Unter den hier beschriebenen Verbindungen weisen insbesondere 3e muskelrelaxierende und antidiabetische und 3a trichomonazide und antivirale Wirksamkeit auf, wahrend mit 3b−d herbizide Wirkungen beobachtet werden. Muscle Relaxants, IV: Monoacylbutyroguanamines Reaction of butyroguanamine (1) with the carboxylic acid anhydrides 2a−f at 80–120°C leads to the monoacylbutyroguanamines 3a−f, the structure of which is supported by IR, 1H-NMR, and mass spectra. Among the compounds described here, particul…

chemistry.chemical_classificationmedicine.drug_classCarboxylic acidPharmaceutical ScienceMuscle relaxantCarboxamideBiological activityButyroguanamineNuclear magnetic resonance spectroscopyMedicinal chemistryAcylationchemistryDrug DiscoverymedicineMass spectrumArchiv der Pharmazie
researchProduct